Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Biomei Biotechnology is a high-tech enterprise based in Changsha, China, specializing in the research, development, and manufacturing of molecular diagnostic solutions. The company focuses on in vitro diagnostic (IVD) reagents and automated instruments, particularly nucleic acid extraction systems and PCR-based detection kits. Their product portfolio addresses critical healthcare needs in infectious disease screening, oncology diagnostics, and personalized medicine, with prominent products for HPV and COVID-19 testing. Biomei integrates advanced biotechnology with automated hardware to provide comprehensive diagnostic workflows for clinical laboratories and hospitals. The company is recognized for its contributions to rapid molecular testing and maintains a significant presence in the domestic Chinese medical device market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Biomei Technology.